Trial Search

Current Search Criteria:

Intervention: Fruquintinib (HMPL-013)
Found 208 matching trials

A Phase IV Study of Elunate® (Fruquintinib) in Chinese Patients

N/A

A phase IV study to characterize safety of Elunate® (Fruquintinib) in Chine...

Status

Completed

Location

Shanghai Dongfang Hospital

Start Date

2019-04-20

Trial ID

NCT04005066

Treatments Being Tested

Phase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer Patients

PHASE2

This is a prospective, Single arm Phase II trial. Patients were eligible to...

Status

Unknown

Location

Chinese Academy of Medical Sciences

Start Date

2020-09-01

Trial ID

NCT04695470

Treatments Being Tested

Fruquintinib in Patients With Metastatic Colorectal Cancer

N/A

FRUQUENT is an observational study in Germany. The goal of the study is to ...

Status

Recruiting

Location

Onkologische Schwerpunktpraxis

Start Date

2025-02-17

Trial ID

NCT06787105

Fruquintinib Plus Camrelizumab and HAIC in the Treatment of Non-MSI-H Advanced Colorectal Cancer

PHASE2

Liver metastasis is the main cause of death in patients with colorectal can...

Status

Not Yet Recruiting

Location

Fudan University Shanghai Cancer Center

Start Date

2024-05

Trial ID

NCT06423937

Fruquintinib Food Effect and Proton Pump Inhibitor Study

PHASE1

The purpose of this is to evaluate the effect of food and the effect of a p...

Status

Completed

Location

WCCT

Start Date

2020-09-24

Trial ID

NCT04645940

A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer

PHASE2

A Phase II Clinical Trial of the Safety and Efficacy of Fruquintinib in Adv...

Status

Unknown

Location

Fudan University Shanghai Cancer Center

Start Date

2022-02

Trial ID

NCT05257122

Treatments Being Tested

A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG

PHASE2

Given that a significant proportion of locally advanced gastric cancer pati...

Status

Recruiting

Location

Henan Cancer Hospital

Start Date

2023-09-12

Trial ID

NCT06774222

Treatments Being Tested

Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy

PHASE2

This is a single-center, single-arm, open-label clinical study, to explore ...

Status

Unknown

Location

Fudan University Shanghai Cancer Center

Start Date

2022-07-12

Trial ID

NCT05435313

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

NA

This study will assess the efficacy and safety profile of fruquintinib in c...

Status

Unknown

Location

Peking University First Hospital

Start Date

2024-02-21

Trial ID

NCT06317298

Treatments Being Tested

Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer

NA

The investigators propose to conduct a single-center, single-arm, Phase I c...

Status

Active Not Recruiting

Location

Colorectal Cancer, West China Hospital

Start Date

2025-02-21

Trial ID

NCT06865521

Treatments Being Tested